Megan Buoey
Lancashire, England
United Kingdom
Review Article
The Role of Psychiatric Drugs and their Minimal-Medication Alternatives in the
Treatment of Schizophrenia
Author(s): Megan BuoeyMegan Buoey
Throughout this report I will be discussing reasons why our current psychiatric system needs improvements concerning the use of psychiatric drugs and how they may not be the answer to the symptoms of schizophrenia. This is an important topic to study considering the health dangers that patients are faced with today as a result of their illness and the medication used for it. I have researched the high success rates of alternative, minimum medication programmes, like open dialogue, which have greater focus on psychotherapies, as opposed to antipsychotic drugs. I have discussed the fundamental flaws with our accepted ideas of schizophrenia, and the implications this neurobiological research has for treatments. I have highlighted the problems with the psychiatric pharmaceutical industry, (particularly drug trials) which markets drugs in a misleading way, creating a paradigm where psychia.. View More»
DOI:
10.4172/2378-5756.1000395